Navigation Links
The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers
Date:4/6/2009

TUCSON, Ariz., and GILROY, Calif., April 6 /PRNewswire/ -- The Department of Surgery at The University of Arizona College of Medicine and OmegaGenesis, Inc., announced an agreement to collaborate on potential remedies to address diabetic foot ulcers.

The agreement includes joint work in support of potential remedies and to identify effective ways to provide information and education to medical professionals and patients globally.

Diabetic foot ulcers are painful, open sores that develop on the feet of people with diabetes. If not diagnosed and treated promptly, diabetic foot ulcers can cause extensive damage to soft-tissue and bone that may necessitate amputation.

"This is a global problem that is profoundly affecting millions of people in the United States and throughout the world," said Dr. David Armstrong, University of Arizona (UA) professor of surgery and the director of the University's Southern Arizona Limb Salvage Alliance (SALSA). "The problem is especially challenging in the developing world, where education and a remedy can have a significant impact."

Estimates indicate people with diabetes have about a 25-percent lifetime risk for developing a foot ulcer; half of these ulcers become infected. Of these, 1 in 4 will undergo amputation, and one amputation is performed every 30 seconds around the world.

The UA Department of Surgery, Dr. Armstrong and Dr. Horacio Rilo, also a UA professor of surgery, have established a new laboratory and are conducting research in the areas of diabetes and prevention of limb amputations resulting from diabetic ulcers. Dr. Rilo also is director of cellular transplantation and co-director of the Arizona Diabetes Center at the UA.

The UA is collaborating with OmegaGenesis to address common goals in testing remedies to address foot ulcers, providing education and in reducing amputations relate
'/>"/>

SOURCE OmegaGenesis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 According to ... ÔÇťAgricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... USD 15,300 million in 2012 and is expected to ... CAGR of 9.5% from 2013 to 2019. , ...
(Date:2/26/2015)... Feb. 26, 2015  Epic Sciences announced today that ... present at the 35th Annual Cowen and Company Health ... the MIT Room, 3rd Floor. The conference will be ... Mass. Epic is developing diagnostic tests of ... and proteomic changes that occur during the course of ...
(Date:2/26/2015)... 26, 2015 Caris Life Sciences® today ... 2015 Genitourinary Cancers Symposium in Orlando, ... of tumor profiling. Both studies utilized Caris Molecular ... to identify biomarkers that shed light on potential ... cell bladder cancer (SCBC). In ...
Breaking Biology Technology:More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5
... announces that a new market research report is ... Discovery Techniques and Applications – A Global Market ... `A more focused discovery process using proteins ... the development stage for quite some time now. ...
... Calif., Sept. 21 TOPICA Pharmaceuticals, Inc. a privately-held ... a sublicense and purchase option agreement with an undisclosed ... the skin in the Americas and Europe. By agreement, ... In conjunction with the sublicensing agreement, TOPICA Pharmaceuticals ...
... NEW YORK and JERUSALEM, Sept. 21 Chiasma, ... Chiasma,s Chairman & CEO, will present an overview of the ... Grand Hyatt, New York, New York, on Wednesday, September 22, ... conducting its second clinical trial of the investigational new drug ...
Cached Biology Technology:Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 2Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 3Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 4Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 5Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 6Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 7Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 8Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 9Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 10Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 11Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 12Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 13Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 14Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 15Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 16Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 17TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication 2Chiasma to Present at the UBS Global Life Sciences Conference 2Chiasma to Present at the UBS Global Life Sciences Conference 3
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... role of sensors and associated instrumentation technologies has ... stringent and sophisticated, requiring innovative development of sensor ... achieve these market demands. Novel tools, techniques and ... will be smaller, have increased sensitivity, require specific ...
... January 21, 2010 The bubbles in your champagne that ... are exhibiting a behavior quite similar to the tiny bubbles found ... But while the champagne bubbles are likely to raise ... and affect the climate. "Bubbles are little packets of gases ...
... A new study published in CMAJ ( Canadian ... severity of H1N1 influenza has found that admissions to ... longer interval between symptom onset and treatment with antivirals ... of First Nations ethnicity were also found to be ...
Cached Biology News:Conference to discuss future of nanotechnology enabled sensors 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 3Disease severity in H1N1 patients 2
lid holder -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... integrated digital microscope and camera system that ... optical adjustment or software installation. Built on ... combines simplicity and advanced technology for users ... viewing of a macro image and a ...
Biology Products: